Hofseth Biocare (Norway) Management Evaluation
| HBC Stock | NOK 1.19 0.03 2.46% |
Hofseth Biocare employs about 9 people. The company is managed by 9 executives with a total tenure of roughly 21 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Inspection of Hofseth Biocare's management performance can provide insight into the company performance.
| Angelika Florvaag Insider Chief Officer |
| Olav Flaten Insider Exec |
Hofseth |
Hofseth Biocare Management Team Effectiveness
The company has return on total asset (ROA) of (0.1942) % which means that it has lost $0.1942 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9478) %, meaning that it generated substantial loss on money invested by shareholders. Hofseth Biocare's management efficiency ratios could be used to measure how well Hofseth Biocare manages its routine affairs as well as how well it operates its assets and liabilities.Hofseth Biocare Workforce Comparison
Hofseth Biocare ASA is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 835. Hofseth Biocare claims roughly 9.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.
The company has Profit Margin (PM) of (1.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.07. Hofseth Biocare ASA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Hofseth Biocare ASA Price Series Summation is a cross summation of Hofseth Biocare price series and its benchmark/peer.
Hofseth Biocare Notable Stakeholders
A Hofseth Biocare stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hofseth Biocare often face trade-offs trying to please all of them. Hofseth Biocare's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hofseth Biocare's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Angelika Florvaag | Chief Officer | Profile | |
| Olav Flaten | Exec | Profile | |
| Tanja Schaffer | EVP GmbH | Profile | |
| Jon Odegard | Chief Officer | Profile | |
| Matt Mixter | Managing America | Profile | |
| Bomi Framroze | Chief Officer | Profile | |
| James Berger | Chief Officer | Profile | |
| Karl Slotsvik | Chief Officer | Profile | |
| Crawford Currie | Head Director | Profile |
About Hofseth Biocare Management Performance
The success or failure of an entity such as Hofseth Biocare ASA often depends on how effective the management is. Hofseth Biocare management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hofseth management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hofseth management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Hofseth BioCare ASA, a biotech company, offers value added biomarine ingredients and finished products for human consumption and pet in Norway. The company was founded in 2000 and is headquartered in lesund, Norway. HOFSETH BIOCARE operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. It employs 44 people.
Hofseth Biocare Workforce Analysis
Traditionally, organizations such as Hofseth Biocare use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hofseth Biocare within its industry.Hofseth Biocare Manpower Efficiency
Return on Hofseth Biocare Manpower
| Revenue Per Employee | 9.7M | |
| Revenue Per Executive | 9.7M | |
| Net Loss Per Employee | 14.1M | |
| Net Loss Per Executive | 14.1M |
Other Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.